Dividends Calendar Earnings Calendar

OCX | OncoCyte Corporation

Healthcare sector
OncoCyte Corporation
Category: Biotechnology company
  • Industry: Biotechnology company

Quick infos

  • Headquarters:   California, United States

Trade prices

  • Volume:
  • Market Cap: 141.03M
  • Prev closed: 4.06
  • Open: 4.14
  • High: 4.55
  • Low: 4.06
  • 52 week low: 1.15
  • 52 week high: 6.57
  • Dividends:No Dividends

Next ER: May 11, 2022  After Market Closes



Top Stories (OCX)

    Company Profile

    Oncocyte is a molecular diagnostics company whose mission is to provide actionable answers at critical decision points across the lung cancer care continuum, with the goal of improving patient outcomes by accelerating and optimizing diagnosis and treatment.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 10, 2022-0.39 / -0.12293.59M / 3.52MBeat!
    November 9, 2021-0.15 / -0.115984K / 1.75MBeat!
    August 10, 2021-0.12 / -0.10062.03M / 1.57MBeat!
    May 17, 2021-0.05 / -0.09871.12M / 838.02K
    March 16, 2021-0.09 / -0.1075503K / 807.9K
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 6, 2022 1.150 1.170
    1.170
    1.140
    		 613.41K -3.36%
    May 5, 2022 1.190 1.180
    1.250
    1.170
    		 559.85K -1.65%
    May 4, 2022 1.210 1.160
    1.220
    1.160
    		 411.71K 3.42%
    May 3, 2022 1.170 1.170
    1.200
    1.155
    		 359.70K 0%
    May 2, 2022 1.170 1.160
    1.180
    1.140
    		 512.73K 0.86%
    Apr 29, 2022 1.160 1.130
    1.160
    1.130
    		 508.46K 2.65%
    Apr 28, 2022 1.130 1.130
    1.140
    1.120
    		 401.57K 0%
    Apr 27, 2022 1.130 1.150
    1.160
    1.130
    		 891.47K -1.74%
    Apr 26, 2022 1.150 1.150
    1.169
    1.140
    		 838.34K 1.77%
    Apr 25, 2022 1.130 1.140
    1.190
    1.120
    		 787.92K -1.74%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2009
    • Employees:33
    • Parent Organization :  BioTime

    News

    News for (OCX)

    This company doesn't provide a dividend.

    Key Persons

    • CFO :  Mitch Levine

    Talk about OncoCyte Corporation below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 11, 2022 (Same day)

    tm dis wen pam prgo zyne bynd fvrr pfgc fosl ste suz 


    Jump to (Finance sites)

    Google   
             

    Their Official Profiles 

    TwitterFacebookLinkedInYoutube

    Other stocks 

    apc rht wfc dltr lrcx tivo low intu mmyt xray ostk rh 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.